B

Biogen

Develops therapies for neurological disorders

PO&T Commercial Asset Development Leader

Business OperationsConfirmed live in the last 24 hours
Full-timeNo salary listed

About the Job

Requirements

  • A BS or equivalent in sciences or engineering is required; an advanced degree (MS, PhD, or MBA) in a relevant biopharmaceutical discipline is preferred.
  • At least 12 years of experience, with a focus on matrix management.
  • A track record of effective matrix leadership on program teams throughout the full product life cycle, such as CMC PO&T line-function subteams or other cross-functional teams in a matrix environment, ideally across an organization.
  • Alliance management experience; global experience is preferred, with understanding of business contracts and management.
  • Experience with CMC, supply chain, or life-cycle-management development from IND through NDA/BLA, including understanding of global registration processes, and technical expertise in a relevant biopharmaceutical development discipline.
  • Experience in the healthcare, biotech, or pharmaceutical industry and demonstrated understanding of cross-functional interdependencies, including R&D, commercial, technical development, and regulatory functions.
  • Strategic, political, organizational, and relationship-development skills.
  • Ability to lead, motivate, and influence strategic direction without authority, and to leverage and develop diverse perspectives and ideas from matrix teams and others.
  • Communication, negotiation, problem-solving, and decision-making abilities.
  • Ability to identify critical program risks and develop strategic or tactical mitigation plans addressing risk, cost, and company reputation.

Responsibilities

  • Oversee development and implementation of a five-year PO&T Asset Strategy and maintain an 18-month rolling Tactical Plan, ensuring alignment with company objectives and enabling the PO&T Leadership team to make informed decisions about the asset.
  • Lead the cross-functional PO&T Asset Team, comprising representatives from each PO&T Line Function, to ensure cohesive and effective execution of the PO&T Asset Strategy and Tactical Plan.
  • Represent PO&T and act as liaison on R&D Program and PDC teams, fostering collaboration and communication among R&D, Commercial, and PO&T in support of assets.
  • Proactively address and manage conflicts related to the Asset Strategy in consultation with the PO&T Governance Committee, balancing PO&T Line Function priorities with the needs of the strategy.
  • Track and assess asset-related impacts on financial metrics such as COGS, E&O, and OPEX, and work with PO&T Line Functions to develop improvement strategies.
  • Develop business cases for significant asset initiatives and secure endorsement and approval from the PO&T Governance Committee.
  • Lead teams representing PO&T disciplines and maintain critical partnerships with relevant program R&D and/or product commercial leaders.
  • Lead and facilitate key aspects of the PO&T vision, including influence and collaboration through oversight of collaborations and interfaces with business development and External Innovation, and data access and connectivity through resource-management and forecasting decision gates and associated knowledge-management initiatives.

About the Company

Biogen

Develops therapies for neurological disorders

Biogen is a global biotechnology company focused on neuroscience. It discovers, develops, and delivers therapies for neurological disorders, such as multiple sclerosis and other neurodegenerative diseases. Its product process starts with research and development to identify potential drugs, followed by clinical testing and regulatory approval, ultimately leading to commercialization and patient treatment. Biogen differentiates itself through a long history (founded in 1978), a deep specialization in neuroscience, and an integrated pipeline that moves ideas from discovery to approved medicines, aiming to create value for shareholders while helping communities. The company’s goal is to advance therapies for neurological diseases to improve patients’ lives and generate sustainable value for stakeholders.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Cambridge, MA
Founded
1978

Recently Posted Jobs

Explore more opportunities at Biogen

See more jobs